For instance, colon tumor location among PI3K-altered CRC patients was significantly associated with poorer survival compared to rectal tumors (p = 0.0177), corroborating prior studies on anatomical variation in CRC outcomes. This evidence concerns the gene PIK3CA and colonic neoplasm.